Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
11.91
-0.09 (-0.75%)
At close: Jun 18, 2026, 4:00 PM EDT
11.95
+0.04 (0.34%)
After-hours: Jun 18, 2026, 5:19 PM EDT
Corvus Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Reiterates $30 | Buy | Reiterates | $30 | +151.89% | May 18, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $33 | Buy | Reiterates | $33 | +177.08% | May 15, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $40 | Buy | Maintains | $40 | +235.85% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $27 | Buy | Reiterates | $27 | +126.70% | May 15, 2026 |
| Barclays | Barclays | Buy Maintains $28 | Buy | Maintains | $28 | +135.10% | May 15, 2026 |
| Jefferies | Jefferies | Buy Maintains $13 → $42 | Buy | Maintains | $13 → $42 | +252.64% | Jan 22, 2026 |